GlassScriptPhysician profile
Jay M Trussler
NPI 1578590725
$11,538.64
in general payments reported to CMS, 2019-2025
52 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $1,505 · 2021: $1,829 · 2022: $1,663 · 2023: $1,717 · 2024: $1,874 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,870 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,869.74 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,555.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,125.77 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $995.21 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $904.08 | 2019-2025 | |
| Glaxosmithkline, LLC. | $848.31 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $718.60 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $439.62 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Amgen INC. | $354.43 | 2019-2024 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $328.72 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $323.43 | 2019-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.64 | 2019-2025 | Jardiance, Ofev |
| Dexcom, INC. | $239.59 | 2021-2024 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $238.54 | 2023-2025 | Caplyta |
| Allergan, INC. | $233.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $231.69 | 2019-2023 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $208.25 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $206.91 | 2022-2025 | Gvoke Hypopen, Recorlev, Keveyis |
| Biohaven Pharmaceutical Holding Company LTD. | $173.46 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $153.90 | 2019-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $152.17 | 2019-2022 | |
| Merz North America, INC. | $150.00 | 2023 | Xeomin |
| Axsome Therapeutics, INC. | $114.30 | 2025 | Auvelity |
| Exact Sciences Corporation | $106.12 | 2023-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $102.36 | 2023-2024 | Accrufer |
| Cardiovascular Systems INC. | $92.78 | 2019 | |
| Esperion Therapeutics, INC. | $90.98 | 2021-2025 | Nexletol |
| Astellas Pharma US INC | $90.30 | 2019-2021 | |
| Abbott Laboratories | $88.91 | 2019-2023 | Freestyle Libre 3 |
| Insulet Corporation | $82.32 | 2022-2023 | Omnipod |
| Mylan Specialty L.P. | $75.07 | 2019-2021 | |
| Eisai INC. | $71.59 | 2020-2021 | |
| Amarin Pharma, INC. | $68.19 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $64.41 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.65 | 2020-2021 | |
| Zyla Life Sciences, INC. | $50.86 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.99 | 2021-2024 | Trintellix |
| Sumitomo Pharma America, INC. | $42.57 | 2023-2025 | Gemtesa |
| Medtronic Minimed, INC. | $42.53 | 2019-2020 | |
| Medtronic, INC. | $39.33 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $38.61 | 2024-2025 | Voquezna |
| Silk Road Medical, INC. | $37.61 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Corcept Therapeutics | $37.51 | 2023 | Korlym |
| Teva Pharmaceuticals USA, INC. | $28.21 | 2020 | |
| Radius Health, INC. | $25.60 | 2019-2020 | |
| Lucid Diagnostics INC. | $23.99 | 2023 | |
| Lundbeck LLC | $20.62 | 2022 | |
| Endogastric Solutions, INC | $19.16 | 2022 | |
| Inspire Medical Systems, INC. | $18.60 | 2025 | Inspire |
| Almatica Pharma LLC | $18.59 | 2021 | |
| Avanir Pharmaceuticals, INC. | $16.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.24 | 2023 | Seglentis |
| E.R. Squibb & Sons, L.L.C. | $15.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Trussler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.